The evolution of stem cell research: the new era of treatment options
Over the past few decades, stem cell research has changed dramatically, giving medical science new possibilities for treatment. In the early 1960s, the identification of stem cells was very exciting and controversial at the same time. These cells possessed extraordinary regenerative medicine potentials as they were capable of differentiating into a wide range of cells.
Embryonic stem cells isolation in the 1990s marked an important milestone that led to greater knowledge about human development as well as opportunities for treating degenerative diseases. However, there were ethical concerns associated with embryonic tissues which made scientists think of alternative ways to use them. Consequently adult stem cell discoveries like hematopoietic types such as those used in bone marrow transplants have been considered successful over many years.
The game changer came with iPS (induced pluripotent) technology that was introduced in 2006 by Yamanaka and his coworkers. By reprogramming adult somatic cells into their embryonic-like state iPS can overcome these problems and offer a bankable approach to patient-specific therapies. Currently iPSCs are playing crucial roles in disease modeling, drug discovery and personalized medicine development.
Stem cell research has advanced from being theoretical science to becoming practical medical treatments. For instance, bone marrow or peripheral blood stem cells transplantations offer regenerative therapies against leukemia, lymphoma and other blood disorders among others. On top of this are advances in MSC (mesenchymal stem cell) therapy that are showing good results for conditions such as orthopedic situations, cardiac repair post myocardial infarction up to neurodegenerative diseases that involves Parkinson’s.
Despite these advances there are still obstacles ahead. Consequently rigorous clinical trials must be carried out together with regulatory oversight which guarantee safety and effectiveness of future treatments using these regenerative cells. Nevertheless, stem cell research trajectory is undeniably moving forward, thus heralding the new era of regenerative medicine that will change all treatment paradigms and improve patient outcomes. Moreover, we are on the verge of a future where regenerative therapies become more mainstream, providing hope and healing to millions of people around the world.
By Dr. Pradeep Mahajan – a pioneer in stem-cell science dedicated to taking it to higher heights in clinical application.